Nurse Practitioner · Meadville, PA
NPI
1437152006
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
16954 Conneaut Lake Rd
Meadville, PA, 16335
Phone (814) 200-9904
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
713 services
Medicare patients, 2024
290
Average age 73
Drug cost, 2024
$2.8M
7,041 prescriptions
Company payments, 2025
$146
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie S Knapka was code 99214 (office e&m - established), 364 times for 197 patients. In total Julie S Knapka billed 713 services in 11 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 364 | 197 | $66.18 | $24K |
| 99215 Office E&M - Established | Office | 277 | 111 | $108.33 | $30K |
| 99213 Office E&M - Established | Office | 23 | 18 | $45.99 | $1,058 |
| 95249 Test - Miscellaneous | Office | 19 | 11 | $44.39 | $843 |
By year: 2022 $61K for 750 services; 2023 $58K for 720 services; 2024 $58K for 713 services.
Medicare prescription drug claims, 2024
In 2024, the drug Julie S Knapka prescribed most often to Medicare patients was Levothyroxine Sodium, with 788 prescriptions and refills. In total Julie S Knapka wrote 7,041 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 788 | 2,035 | 198 | $8,389 |
| Metformin Hcl Er Metformin Hcl | 655 | 1,632 | 172 | $11K |
| Mounjaro Tirzepatide | 577 | 778 | 89 | $794K |
| Synthroid Levothyroxine Sodium | 441 | 968 | 88 | $36K |
| Atorvastatin Calcium Generic | 349 | 863 | 95 | $3,894 |
| Jardiance Empagliflozin | 325 | 686 | 74 | $381K |
| Metformin Hcl Generic | 312 | 793 | 84 | $2,433 |
| Glipizide Generic | 306 | 754 | 76 | $2,351 |
| Glipizide Er Glipizide | 265 | 708 | 72 | $4,009 |
| Trulicity Dulaglutide | 264 | 390 | 51 | $368K |
| Ozempic Semaglutide | 218 | 339 | 54 | $316K |
| Farxiga Dapagliflozin Propanediol | 213 | 433 | 61 | $227K |
| Rosuvastatin Calcium Generic | 137 | 301 | 30 | $3,812 |
| Simvastatin Generic | 128 | 354 | 38 | $1,173 |
| Lisinopril Generic | 109 | 281 | 28 | $605 |
Brand drugs: 2,948 claims; generic drugs: 3,916 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie S Knapka $146 ($146 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $86.86.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.